Related Experiment Video
Updated: Sep 12, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Screening for prostate cancer. Does it make a difference?
1Division of General Internal Medicine, Duke University Medical Center, Durham 27710.
Abstract:
Susan's father, Sidney Smith, is 63 years old. Recently he has heard on radio and television talk shows that a new test, the Prostate Specific Antigen (PSA), is now available to check for prostate cancer. During his general check-up visit to your office, he mentions this test and wants to know more. He is in excellent health and his urinary review of systems reveals only a slight decrease in the intensity of his urinary stream. On examination he has moderate prostate enlargement but no palpable nodules. His stool test is Hemoccult negative. The remainder of his examination is normal.

